Clinical Trial Update: PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial update for PROTECT evaluating prophylaxis to prevent thromboembolism in critically ill patients in the intensive care setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Venous Thrombosis
• Venous Thromboembolism

Snippet

Sponsor: McMaster University | Conditions: Critical Illness, Deep Venous Thrombosis | Phase 3 | Status: COMPLETED